An observational study in Peyronie's Disease, sponsored by Endo Pharmaceuticals. Terminated at 7 sites in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-16.
Sponsored by Endo Pharmaceuticals (part of Keenova Therapeutics plc) · Observational
This is an observational study, meaning participants will not receive any investigational treatment as part of this study.
Researchers will collect real-world data (RWD) to gain a more in-depth knowledge of the treatment of Peyronie's Disease (PD) to evaluate the management of PD.
Each participant of the study will have their data collected from the date of confirmed diagnosis of PD to the date of enrollment in the registry, post consent. Data will be collected from the participant's clinical records as well as from the participant directly. Data will be collected through Pulse Infoframe's technology platform.
47 studies on the registry are indexed under Penile Induration; 10 are open to participants now.
Browse Penile Induration studies →Endo Pharmaceuticals is the lead sponsor of 99 studies on the registry; none are open to participants now.
Of its 16 completed or terminated interventional studies of FDA-regulated products, 14 (88%) have results posted.
First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc.
Counted across the registry records on this site, refreshed daily.
Participants with a confirmed diagnosis of PD will be enrolled in the United States.
Key Inclusion Criteria:
Key Exclusion criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Number of Participants Receiving Each Treatment Type for PD
Time frame: Up to 12 months
Change from Baseline in Peyronie's Disease Questionnaire (PDQ) Score
Time frame: Up to 12 months
Change from Baseline in International Index of Erectile Function (IIEF) Score
Time frame: Up to 12 months
Change from Baseline in Patient Health Questionnaire-9 (PHQ-9) Score
Time frame: Up to 12 months
Change from Baseline in Beck Anxiety Inventory (BAI) Scale Score
Time frame: Up to 12 months
Participant Satisfaction Questionnaire
Time frame: Up to 12 months
Number of Participants Receiving Post-Procedural Care by the Treating Physician
Time frame: Up to 12 months
Ran from Jun 2023 to primary completion in Feb 2024, 8 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.